3,4-dimethoxybenzylamine: RN given for parent cpd; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
ID Source | ID |
---|---|
PubMed CID | 79832 |
SCHEMBL ID | 44393 |
MeSH ID | M0190825 |
Synonym |
---|
HMS1749O10 |
4-13-00-02582 (beilstein handbook reference) |
3,4-dimethoxybenzylamine |
benzenemethanamine,4-(dimethoxy)- |
veratrylamine |
nsc271740 |
benzenemethanamine,4-dimethoxy- |
5763-61-1 |
benzylamine,4-(dimethoxy)- |
nsc-271740 |
wln: z1r co1 do1 |
3,4-(dimethoxy)benzylamine |
inchi=1/c9h13no2/c1-11-8-4-3-7(6-10)5-9(8)12-2/h3-5h,6,10h2,1-2h |
3,4-dimethoxybenzylamine, 97% |
benzylamine, 3,4-dimethoxy- |
nsc 271740 |
benzenemethanamine, 3,4-dimethoxy- |
einecs 227-287-7 |
brn 0511575 |
STK397311 |
1-(3,4-dimethoxyphenyl)methanamine |
(3,4-dimethoxyphenyl)methanamine |
AKOS000120468 |
D4024 |
FT-0635841 |
BBL027681 |
SCHEMBL44393 |
veratrylamin |
3,4-dimethoxyphenylmethyl amine |
3,4-dimethoxy -benzylamine |
3,4-dimethoxybenzenemethanamine |
3,4-dimethoxy benzyl amine |
1-(3,4-dimethoxyphenyl)methaneamine |
1-(aminomethyl)-3,4-dimethoxybenzene |
3,4-dimethoxybenzyl-amine |
3,4-dimethoxy-benzylamine |
3,4-dimethoxybenzyl amine |
3,4-dimethoxy benzylamine |
3,4-di-methoxybenzylamine |
benzylamine, 3,4-(dimethoxy)- |
(3,4-dimethoxyphenyl)methanamine # |
W-105453 |
TS-01461 |
F0001-1502 |
DTXSID50206292 |
mfcd00008116 |
(3,4-dimethoxybenzyl)amine |
BCP18641 |
KQA442BL6W |
[(3,4-dimethoxyphenyl)methyl]amine |
EN300-17919 |
JHD , |
CK2400 |
CS-W017837 |
Assay ID | Title | Year | Journal | Article |
---|---|---|---|---|
AID588519 | A screen for compounds that inhibit viral RNA polymerase binding and polymerization activities | 2011 | Antiviral research, Sep, Volume: 91, Issue:3 | High-throughput screening identification of poliovirus RNA-dependent RNA polymerase inhibitors. |
AID540299 | A screen for compounds that inhibit the MenB enzyme of Mycobacterium tuberculosis | 2010 | Bioorganic & medicinal chemistry letters, Nov-01, Volume: 20, Issue:21 | Synthesis and SAR studies of 1,4-benzoxazine MenB inhibitors: novel antibacterial agents against Mycobacterium tuberculosis. |
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (16.67) | 18.7374 |
1990's | 3 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (22.06) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 6 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |